Anti-BrdU antibody ValidAbTM

(HB9919)
Technical documents: SDS Datasheet

Product overview

Name Anti-BrdU antibody ValidAbTM
Host Mouse
Clonality Monoclonal
Target BrdU
Description

Antibody to BrdU - thymidine analogue incorporated into DNA during replication therefore used as a marker of proliferating cells. Part of the ValidAb™ range of highly validated, data-rich antibodies. 

Write Your Own Review
You're reviewing:Anti-BrdU antibody ValidAb<sup>TM</sup>
Rate this item:

Validation data

Figure 1. BrdU Immunoreactivity in HEK293T cells either serum starved or starved then stimulated with 20% serum.

Serum starvation inhibits cell proliferation resulting in no BrdU staining due to a lack of DNA replication. Serum stimulation of starved cells causes cell cycle resumption and DNA replication therefore strong BrdU staining. Method: HEK293T cells were cultured on coverslips in 10% FBS, 1% pen/strep in DMEM until approximately 50% confluency. Cells were then cultured in serum free media for 24 hours. 10µm BrdU (HB0979) was added to all coverslips then half were incubated in 20% FBS containing media for 2hrs while the remainder were kept in DMEM. Cells were then fixed in 4% PFA before being permeabilised with 0.1% Triton X-100 and blocked in 1% BSA, 300mM glycine. HB9919 was incubated overnight at 4°C at a concentration of 1µg/ml (1:1000 dilution). Following washing, a goat polyclonal anti-mouse Dylight 488 conjugated secondary antibody (Thermofisher 35503, 1:300 dilution) was incubated for one hour. DAPI (HB0747) was used at 1µg/ml to visualise cell nuclei. For more detail please see our ICC protocol. Images were captured using a Leica SPE confocal laser scanning microscope coupled to a Leica DMi8 inverted epifluorescence microscope. Images were all taken using the same settings for each condition (40x objective, 0.44µm z-spacing, 405nm: 24.5% power @ 575V gain, 488nm: 23.4% power @ 768V gain). Following capture, ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676-682) was used to perform a maximum Z projection.

Figure 2. BrdU staining reveals proliferation in HEK293T cells using HB9919

Strong BrdU immunoreactivity can be seen caused by the rapid proliferation of HEK293T cells in culture leading to high levels of BrdU integration during DNA replication. Method: HEK293T cells were cultured on coverslips in 10% FBS, 1% pen/strep in DMEM in the presence of 10µm BrdU (HB0979). When cells reached confluency they were fixed with 4% PFA before being permeabilised with 0.1% Triton X-100 and blocked in 1% BSA, 300mM glycine. HB9919 was incubated overnight at 4°C at a concentration of 2µg/ml (1:500 dilution). Following washing, a goat polyclonal anti-mouse Dylight 488 conjugated secondary antibody (Thermofisher 35503, 1:300 dilution) was incubated for one hour. DAPI (HB0747) was used at 1µg/ml to visualise cell nuclei. For more detail please see our ICC protocol. Images were captured using a Leica SPE confocal laser scanning microscope coupled to a Leica DMi8 inverted epifluorescence microscope. The image was taken using a 40x objective, 0.44µm z-spacing, 405nm (24.5% power @ 575V gain) and 488nm (23.4% power @ 768V gain) lasers. Following capture, ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676-682) was used to perform a maximum Z projection.

Figure 3. Mixed proliferating and non-proliferating cells in mixed neuronal cultures visualised using HB9919.

BrdU staining can be seen amongst the proliferating cells found within mixed neuronal cultures while cells not actively dividing are unstained. Method: neurones were cultured from PND2 rats following established protocols (Brewer and Torricelli, 2007. Nat Protoc 2, 1490–1498). 10µM BrdU was added to cultures on DIV7 before cells were fixed with 4% PFA on DIV21. Cells were permeabilised with 0.1% Triton X-100 followed by incubation with 2M HCl for 20 minutes at 37°C. Cells were incubated in 0.1M borate buffer (pH8.5) for 10 minutes before being blocked in 1% BSA, 300mM glycine. HB9919 was incubated overnight at 4°C (2µg/ml, 1:500 dilution) followed by a one hour incubation with a polyclonal goat anti-mouse Dylight 488 conjugated secondary antibody (Thermofisher 35503, 1:300 dilution). DAPI (HB0747) was used at 1µg/ml to visualise cell nuclei. For more detail please see our ICC protocol. The image was captured using a Leica DMi8 inverted epifluorescence microscope connected to a Photometric Prime95B camera. The image was taken using a 40x objective and 1.0µm z-spacing with DAPI (95ms exposure) and L5 (112.7ms exposure) filters. Following capture, ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676-682) was used to subtract background and perform a maximum Z projection.

Figure 4. Proliferating cell in mixed neuronal cultures visualised with HB9919 staining.

A proliferating cell within mixed neuronal cultures is visualised having incorporated BrdU into its DNA. Method: neurones were cultured from PND2 rats following established protocols (Brewer and Torricelli, 2007. Nat Protoc 2, 1490–1498). 10µM BrdU was added to cultures on DIV7 before cells were fixed with 4% PFA on DIV21. Cells were permeabilised with 0.1% Triton X-100 followed by incubation with 2M HCl for 20 minutes at 37°C. Cells were incubated in 0.1M borate buffer (pH8.5) for 10 minutes before being blocked in 1% BSA, 300mM glycine. HB9919 was incubated overnight at 4°C (0.5µg/ml, 1:2000 dilution) followed by a one hour incubation with Rhodamine Phalloidin TRITC (HB8621, 183nM) and a polyclonal goat anti-mouse Dylight 488 conjugated secondary antibody (Thermofisher 35503, 1:300 dilution). DAPI (HB0747) was used at 1µg/ml to visualise cell nuclei. For more detail please see our ICC protocol. Images were captured using a Leica SPE confocal laser scanning microscope coupled to a Leica DMi8 inverted epifluorescence microscope. The image was taken using a 63x objective, 0.28µm z-spacing, 405nm (29.0% power @ 598V gain), 488nm (1% power @ 907V gain) and 532nm (38.0% power @ 702V gain) lasers. Following capture, deconvolution was carried out using Huygens Professional (SVI) then ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676-682) was used to perform a maximum Z projection.

Figure 5. Proliferating cell in mixed neuronal cultures visualised with HB9919 staining.

A proliferating cell within mixed neuronal cultures is visualised having incorporated BrdU into its DNA. Method: neurones were cultured from PND2 rats following established protocols (Brewer and Torricelli, 2007. Nat Protoc 2, 1490–1498). 10µM BrdU was added to cultures on DIV7 before cells were fixed with 4% PFA on DIV21. Cells were permeabilised with 0.1% Triton X-100 followed by incubation with 2M HCl for 20 minutes at 37°C. Cells were incubated in 0.1M borate buffer (pH8.5) for 10 minutes before being blocked in 1% BSA, 300mM glycine. HB9919 was incubated overnight at 4°C (0.25µg/ml, 1:4000 dilution) followed by a one hour incubation with Rhodamine Phalloidin TRITC (HB8621, 183nM) and a polyclonal goat anti-mouse Dylight 488 conjugated secondary antibody (Thermofisher 35503, 1:300 dilution). DAPI (HB0747) was used at 1µg/ml to visualise cell nuclei. For more detail please see our ICC protocol. Images were captured using a Leica SPE confocal laser scanning microscope coupled to a Leica DMi8 inverted epifluorescence microscope. The image was taken using a 63x objective, 0.24µm z-spacing, 405nm (29.0% power @ 663V gain), 488nm (1% power @ 938V gain) and 532nm (30.1% power @ 685V gain) lasers. Following capture, deconvolution was carried out using Huygens Professional (SVI) then ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676-682) was used to perform a maximum Z projection.

Figure 6. Concentration response of HB9919 staining in mixed neuronal cultures.

HB9919 identifies proliferating cells in mixed neuronal cultures at dilutions as low as 1:4000 (0.25µg/ml) while not showing any cross-reactivity in the absence of BrdU. Method: neurones were cultured from PND2 rats following established protocols (Brewer and Torricelli, 2007. Nat Protoc 2, 1490–1498). 10µM BrdU was added to cultures on DIV7 before cells were fixed with 4% PFA on DIV21. Cells were permeabilised with 0.1% Triton X-100 followed by incubation with 2M HCl for 20 minutes at 37°C. Cells were incubated in 0.1M borate buffer (pH8.5) for 10 minutes before being blocked in 1% BSA, 300mM glycine. HB9919 was incubated at 4°C overnight in dilutions ranging from 1:500 (2µg/ml) to 1:4000 (0.25µg/ml). This was followed by a one hour incubation with Rhodamine Phalloidin TRITC (HB8621, 183nM) and a polyclonal goat anti-mouse Dylight 488 conjugated secondary antibody (Thermofisher 35503, 1:300 dilution). DAPI (HB0747) was used at 1µg/ml to visualise cell nuclei. For more detail please see our ICC protocol. Images were captured using a Leica DMi8 inverted epifluorescence microscope (63x objective) connected to a Photometric Prime95B camera. Exposure settings were as follows:

  • 1:500 (no BrdU) – DAPI_LP: 40.1ms, FITC_LP: 361ms, RHOD_LP: 149.3ms
  • 1:500 – DAPI_LP: 40.1ms, FITC_LP: 115.5ms, RHOD_LP: 149.2ms
  • 1:1000 – DAPI_LP: 40.1ms, FITC_LP: 92.5ms, RHOD_LP: 43.7ms
  • 1:2000 – DAPI_LP: 40.1ms, FITC_LP: 92.5ms, RHOD_LP: 243.6ms
  • 1:4000 – DAPI_LP: 40.1ms, FITC_LP: 159.0ms, RHOD_LP: 114.9ms


Following capture ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676-682) was used to subtract background and perform a maximum Z projection.

Product information

Immunogen

BrdU conjugated with hemocyanine.

Clone number MoBu-1
Isotype IgG1
Purification

Protein A affinity chromatography

Formulation Lyophilised. When reconstituted contains PBS with 15mM sodium azide and 1% recombinant albumin
Predicted species reactivity NA
Tested species reactivity NA

Tested applications

Applications ICC, IHC(IF)
IHC(IF) optimal concentration

1µg/ml (1:1000) as measured in rat hippocampus.

ICC optimal concentration

1µg/ml (1:1000) as measured in mixed neuronal cell cultures.

Product specific protocols

The dense structure of chromatin can prevent anti-BrdU antibodies binding to the intercalated BrdU within the DNA helix. Denaturing the DNA can therefore improve staining:

  • Incubate brain sections or coverslips in 2M HCl for 30 minutes at 37°C
  • Incubate with 0.1M sodium tetraborate (2 x 5 minute incubations) to neutralise the acid
  • Wash in PBS / TBS (3 x 5 minute washes)
  • Continue with immunostaining (see our IHC(IF) and ICC protocols for more information)

For more details on BrdU immunostraining please see Wojtowicz and Kee., 2006

Positive control

Any cell line or tissue that has had BrdU administered to it while cells are replicating

Negative control

Any cell line or tissue that has not been exposed to BrdU

Open data link

Please follow this link to the OSF.

Target information

Structure image  Chemical Structure

Storage & Handling

Storage instructions

-20°C then use reconstitution advice

Reconstitution advice

We recommend reconstituting with either:


  • dH2O and storing at 4°C
  • 50:50 ratio of dH2O to glycerol and storing at -20°C
  • dH2O then aliquot and store at -80°C


Take care when opening as the precipitate is extremely light and can easily be lost if disturbed. When reconstituting make sure that the antibody is thoroughly dissolved by pipetting up and down before giving the antibody a brief spin at <10,000g to make sure that all material is recovered and at the bottom of the tube.


For more information please see our detailed guide on storing and using your antibody

Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

FAQs

Do you supply BrdU compatible with this antibody?

We sell a range of different pack sizes of BrdU which we have succesfully used with this antibody. Please follow this link to find out more information.

What counterstains do you recommend for use in ICC and IHC with this BrdU antibody?

We recommend using either DAPI, Hoechst 33342 or Propidium Iodide to label cell nuclei. In some experiments it is also helpful to label actin filaments in the cytoskeleton using a Phalloidin conjugate such as FITC Phalloidin or Rhodamine Phalloidin-TRITC.

What protocols are available for use with this BrdU antibody?

We have made a comprehensive collection of protocols that we have used in our experiments to validate this BrdU antibody. Adittionally for using BrdU to measure neurogenesis please refer to Wojtowicz and Kee et al., 2006. for a detailed protocol and troubleshooting.

What guarantee do you have that my BrdU antibody will perform as expected?

We guarantee that your BrdU antibody will work for the applications and species we list on the datasheet. If the antibody fails to perform as expected then we are happy to offer a 100% refund guarantee. For more details please see our guarantee policy.

Any other questions?

For any other questions about our antibody products please see our technical FAQs for antibodies

References for Anti-BrdU antibody ValidAbTM

References are publications that support the biological activity of the product
  • Proliferation assays (BrdU and EdU) on skeletal tissue sections.

    Mead TJ et al (2014) Methods in molecular biology (Clifton, N.J.) 1130 : 233-243
  • The use of bromodeoxyuridine incorporation assays to assess corneal stem cell proliferation.

    Crane AM et al (2013) Methods in molecular biology (Clifton, N.J.) 1014 : 65-70
  • BrdU assay for neurogenesis in rodents.

    Wojtowicz JM et al (2006) Nature protocols 1 : 1399-405
  • Neurogenesis in the adult human hippocampus.

    Eriksson PS et al (1998) Nature medicine 4 : 1313-7